Glucose-mediated regulation of transforming growth factor-beta (TGP-β) and TGP-β receptors in human retinal endothelial cells

Current Eye Research

Volumn 19, Issue 2, 1999, Pages 162-170

  Pascal, Monique M ^a   Forrester, John V ^a   Knott, Rachel M ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

diabetic retinopathy; Glucose; Human; Retinal endothelial cells; TGF receptors; Transforming growth factor beta (TGF )

Indexed keywords

GLUCOSE; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ARTICLE; BINDING AFFINITY; DIABETIC RETINOPATHY; DISEASE COURSE; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DENSITY; RETINA CELL;

BINDING, COMPETITIVE; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; GLUCOSE; HUMANS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RETINAL VESSELS; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA;

EID: 0032868042     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1076/ceyr.19.2.162.5332     Document Type: Article

References (46)

1. Klein R. The epidemiology of diabetic eye disease. In: Textbook of Diabetes. Oxford: Blackwell Science; 1997; chap 44.
2. Forrester JV, Knott RM, McIntosh LC. Pathogenesis of proliferative diabetic retinopathy and maculopathy. Diab Ann. 1993;7:178-191.
3. Vinores SA, Campochiaro PA, May EE, Blaydes SH. Progressive ultrastructural damage and thickening of the basement membrane of the retinal pigment epithelium in spontaneously diabetic rats. Exp Eye Res. 1988;46:545-558.
4. Dirks C, Williams EH, Campochiaro PA. High glucose concentrations inhibit protein synthesis in retinal pigment epithelium in vitro. Exp Eye Res. 1987;44:951-958.
5. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New Eng J Med. 1993;329:977-986.
6. Natarajan R, Bai W, Lanting L, Gonzales N, Nadler J. Effects of high glucose on vascular endothelial growth factor expression in vascular smooth muscle cells. Am J Physiol. 1997;273:H2224-H2231.
7. Boulton M, Gregor Z, McLeod D, Charteris D, Jarvis-Evans J, Moriarty P, Khaliq A, Foreman D, Allamby D, Bardsley B. Intravitreal growth factors in proliferative diabetic retinopathy: Correlation with neovascular activity and glycaemic management. Brit J Ophthal 1997;81:228-233.
8. Kuzuya M, Satake S, Ai S. Asai T, Kanda S. Ramos MA, Miura H, Ueda M, Iguchi A. Inhibition of angiogenesis on glycated collagen lattices. Diabetologia. 1998;41:491-499.
9. Zhang D, Jacobberger JW. TGF-β1 perturbation of the fibroblast cell cycle during exponential growth: switching between negative and positive regulation. Cell Proliferation. 1996;29:289-307.
10. Kagami S, Kuhara T, Yasumoto K. Transforming growth factor beta (TGF-β) stimulates the expression of beta 1 integrins and adhesion by rat mesangial cells. Exp Cell Res. 1996;229:1-6.
11. Akagi Y. Inhibition of TGF-β1 expression by antisense oligonucleotides suppressed extracellular matrix accumulation in experimental glomerulonephritis. Kidney Int. 1996;50:148-155.
12. Shankland SJ, Scholey JW. Expression of TGF-β 1 during diabetic renal hypertrophy. Kidney Int. 1994;46:430-442.
13. Mackay K, Striker LJ, Stauffer JW, Doi T, Agodoa LY, Striker GE. Transforming growth factor beta. Murine glomerular receptors and responses of isolated glomerular cells. J Clin Invest. 1989;83:1160-1167.
14. Antonelli-Orlidge A, Saunders KB, Smith SR, D' Amore PA. An activated form of transforming growth factor beta is produced by co-cultures of endothelial cells and pericytes. Proc Nat Acad Sci. 1989;86:4544-4548.
15. Noda M, Rodan GA. Type beta transforming growth factor (TGF-β) regulation of alkaline phosphatase expression and other phenotype-related mRNAs in osteoblastic rat osteosarcoma cells. J Cell Physiol. 1987;133:426-437.
16. Massague J. The transforming growth factor beta family. Ann Rev Cell Biol. 1990;6:597-641.
17. Wakefield LM, Smith DM, Flanders KC Sporn MB. Latent transforming growth factor beta from human platelets. A high molecular weight complex containing precursor sequences. J Biol Chem. 1988;263:7646-7654.
18. Lyons RM, Keski-Oja J, Moses HL. Proteolytic activation of latent transforming growth factor beta in the control of epidermal proliferation. J Cell Biol. 1998;106: 1659-1665.
19. Battegay EJ, Raines EW, Seifert RA, Bowen-Pope DF, Ross R. TGF-β induces bimodal proliferation of connective tissue via complex control of an autocrine PDGF loop. Cell. 1990;63:515-524.
20. Gadjusek CM, Luo Z, Mayberg MR. Basic fibroblast growth factor and transforming growth factor beta-1: synergistic mediators of angiogenesis in vitro. J Cell Physiol. 1993;157:133-144.
21. Tada K, Fukunaga T, Wakabayashi Y. Inhibition of tubular morphogenesis in human microvascular endothelial cells by coculture with chondrocytes and involvement of transforming growth factor beta: a model of avascularity in human cartilage. Bioch Biophys Acta. 1994;1201:135-142.
22. Yingling JM, Wang XF, Bassing CH. Signalling by the transforming growth factor beta receptors. Bioch Biophys Acta. 1995;1242:115-136.
23. Miyazono K. TGF-β receptors and signal transduction. Int J Haematol. 1997;65(2):97-104.
24. McIntosh LC, Muckersie L, Forrester JV. Retinal capillary endothelial cells prefer different substrates for growth and migration. Tissue and Cell. 1988;20:193-209.
25. Knott RM, Robertson M, Forrester JV. Regulation of glucose transporter (GLUT 3) and aldose reductase mRNA in bovine retinal endothelial cells and retinal pericytes in high glucose and high galactose culture. Diabetologia. 1993;36:808-812.
26. Knott RM, Robertson M, Muckersie E, Forrester JV. Regulation of glucose transporters (GLUT-1 and GLUT-3) in human retinal endothelial cells. Biochem J. 1996;318: 313-317.
27. Levitz SM, Diamond RD. Mechanisms of resistance of Aspergillus fumigatus conidia to killing by neutrophils in vitro. J Infect Diseases. 1985;152:938-945.
28. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidinium thyocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
29. Varedi M, Tredget EE, Scott PG, Shen YS, Ghahary A. Alteration in cell morphology triggers transforming growth factor beta 1 collagenase and tissue inhibitor of metalloproteinases-1 expression in normal and hypertrophic scar fibroblasts. J Invest Dermatol. 1995;104:118-123.
30. Tsushima H, Kawata S, Tamura S. High levels of transforming growth factor beta 1 in patients with colorectal cancer: association with disease progression. Gastroenterology. 1996;110:375-380.
31. Tripathi RC, Navaneet SCB, Kolli SP, Tripathi BJ. Trabecular cells express receptors that bind TGF-β 1 and TGF-β 2: a qualitative and quantitative characterisation. Invest Ophthalmol Vis Sci. 1993;34(5):260-263.
32. Cagliero E, Roth T, Taylor AW, Lorenzi M. The effects of high glucose on human endothelial cell growth and gene expression are not mediated by transforming growth factor beta. Lab Invest. 1995;73(5):667-673.
33. Cosio FG. Effects of high glucose concentrations on human mesangial cell proliferation. J Am Soc Neph. 1995;5:1600-1609.
34. Chaudhury AR, D'Amore PA. Endothelial cell regulation by transforming growth factor beta. J Cell Biochem. 1991;47:224-229.
35. Datto MB, Yu Y, Wang XF. Functional analysis of the transforming growth factor beta response elements in the WAF1/Cip1/p21 promoter J Biol Chem. 1995;270(48): 28623-8.
36. Flaumenhaft R, Abe M, Mignatti P, Rifkin DB. Basic fibroblast growth factor-induced activation of transforming growth factor beta in endothelial cell regulation of plasminogen activator activity. J Cell Biol. 1992;118(4): 901-909.
37. Knott RM, Robertson M, Muckersie E, Forrester JV. Glucose dependent regulation of DNA synthesis in bovine retinal endothelial cells. Curr Eye Res. 1998;17:1-8.
38. Ishida K, Yamashita H, Katagari H, Oka Y. Regulation of glucose transporter 1 (GLUT 1) gene expression by epidermal growth factor in bovine corneal endothelial cells. Jap J Ophthal. 1995;39:225-232.
39. Wakefield LM, Smith DM, Masui T, Harris CC, Sporn MB. Distribution and modulation of the cellular receptors for transforming growth factor beta. J Cell Biol. 1987;105:965-975.
40. Chen RH, Ebner R, Derynk R. Inactivation of the type II receptor reveals two receptor pathways for the diverse TGF-β activities. Science. 1993;260:1335-1338.
41. Sankar S, Mahooti-Brooks N, Bensen L, McCarthy YL, Centrella M, Madri JA. Modulation of transforming growth factor beta receptor levels on microvascular endothelial cells during in vitro angiogenesis. J Clin Invest. 1996;97(6):1436-1446.
42. Segarini PR. TGF-β receptors : a complicated system of multiple binding proteins. Bioch Biophys Acta. 1993;1155: 269-275.
43. Wahl S, Hunt DA, Wakefield LM. Transforming growth factor beta induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci. 1987;84:5788-5792.
44. Schroder S, Palinski W, Schmid-Schonbein GW. Activated monocytes and granulocytes capillary nonperfusion and neovascularization in diabetic retinopathy. Am J Pathol. 1991;139:81-100.
45. Park I, Kiyamoto H, Abboud SL, Abboud HE. Expression of transforming growth factor beta and type IV collagen in early streptozotocin-induced diabetes. Diabetes. 1997;46:473-480.
46. Wikner NE, Elder JT, Persichitte KA, Mink PC. Transforming growth factor beta modulates plasminogen activator activity and plasminogen activator inhibitor expression in human keratinocytes in vitro. J Invest Dermatol. 1993;95(5):607-613.